Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 5:13:1063294.
doi: 10.3389/fphys.2022.1063294. eCollection 2022.

Metabolic regulation of stress erythropoiesis, outstanding questions, and possible paradigms

Affiliations
Review

Metabolic regulation of stress erythropoiesis, outstanding questions, and possible paradigms

Baiye Ruan et al. Front Physiol. .

Abstract

Steady state erythropoiesis produces new erythrocytes at a constant rate to replace the senescent cells that are removed by macrophages in the liver and spleen. However, infection and tissue damage disrupt the production of erythrocytes by steady state erythropoiesis. During these times, stress erythropoiesis is induced to compensate for the loss of erythroid output. The strategy of stress erythropoiesis is different than steady state erythropoiesis. Stress erythropoiesis generates a wave of new erythrocytes to maintain homeostasis until steady state conditions are resumed. Stress erythropoiesis relies on the rapid proliferation of immature progenitor cells that do not differentiate until the increase in serum Erythropoietin (Epo) promotes the transition to committed progenitors that enables their synchronous differentiation. Emerging evidence has revealed a central role for cell metabolism in regulating the proliferation and differentiation of stress erythroid progenitors. During the initial expansion stage, the immature progenitors are supported by extensive metabolic changes which are designed to direct the use of glucose and glutamine to increase the biosynthesis of macromolecules necessary for cell growth and division. At the same time, these metabolic changes act to suppress the expression of genes involved in erythroid differentiation. In the subsequent transition stage, changes in niche signals alter progenitor metabolism which in turn removes the inhibition of erythroid differentiation generating a bolus of new erythrocytes to alleviate anemia. This review summarizes what is known about the metabolic regulation of stress erythropoiesis and discusses potential mechanisms for metabolic regulation of proliferation and differentiation.

Keywords: anabolic metabolism; epigenetic regulation; glycolysis; stress erythropoiesis; tissue regeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Initiation of stress erythropoiesis and the expansion of immature SEPs. Figure depicts the inflammatory signals that initiate stress erythropoiesis, the formation of the stress erythropoiesis niche and the expansion of a transient amplifying population of immature stress progenitors. Included in the figure are observed signals and potential changes that would be predicted to occur as discussed in the review.
FIGURE 2
FIGURE 2
The transition to differentiation and the terminal differentiation of stress erythroid progenitors. The figure depicts the transition to differentiation and terminal differentiation. Changes in signals and metabolism in the niche and progenitors are indicated.

Similar articles

Cited by

References

    1. Akilesh H. M., Buechler M. B., Duggan J. M., Hahn W. O., Matta B., Sun X., et al. (2019). Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes. Science 363 (6423), eaao5213. Epub 2019/01/12PubMed PMID: 30630901; PMCID: PMC6413693. 10.1126/science.aao5213 - DOI - PMC - PubMed
    1. An S., Kumar R., Sheets E. D., Benkovic S. J. (2008). Reversible compartmentalization of de novo purine biosynthetic complexes in living cells. Science 320 (5872), 103–106. Epub 2008/04/05PubMed PMID: 18388293. 10.1126/science.1152241 - DOI - PubMed
    1. Arezes J., Foy N., McHugh K., Sawant A., Quinkert D., Terraube V., et al. (2018). Erythroferrone inhibits the induction of hepcidin by BMP6. Blood 132 (14), 1473–1477. Epub 2018/08/12PubMed PMID: 30097509; PMCID: PMC6238155 funding from Pfizer. N.F., A.S., V.T., A.B., M.T., E.R.L., O.C., M.L., and R.J. are Pfizer employees. N.F., O.C., R.J., J.A., K.M., S.J.D., and H.D. are named inventors on a patent application currently under evaluation. The remaining authors declare no competing financial interests. 10.1182/blood-2018-06-857995 - DOI - PMC - PubMed
    1. Asfaha S. (2015). Intestinal stem cells and inflammation. Curr. Opin. Pharmacol. 25, 62–66. Epub 2015/12/15PubMed PMID: 26654865. 10.1016/j.coph.2015.11.008 - DOI - PubMed
    1. Azzolin L., Panciera T., Soligo S., Enzo E., Bicciato S., Dupont S., et al. (2014). YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell 158 (1), 157–170. Epub 2014/07/01PubMed PMID: 24976009. 10.1016/j.cell.2014.06.013 - DOI - PubMed